Atlas AI develops custom software, data engineering solutions, and AI models tailored for the bioinformatics sector. They build scalable platforms and modular tools to accelerate R&D, optimize protocols, and integrate complex datasets for clients in biotech, pharma, and materials science. The company focuses on delivering reliable, high-performance solutions that enhance productivity and support scientific breakthroughs.
Funding
$680K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current cell production methods at scale lack efficient bioinformatic and AI tools for assessing cell health in large-scale manufacturing. This leads to an inability to monitor, control, and predict cell behavior in-vitro, resulting in loss of cell functionality, genetic drifts over time, and batch losses due to cells failing to meet quality standards. Existing induced pluripotent stem cells (iPSCs) can also exhibit batch-to-batch inconsistencies and heterogeneity.
Solution
Alt Atlas provides an AI-driven toolkit and novel stem cell lines to enhance cell culture control and scalability. The platform leverages predictive AI to efficiently assess cell health in large-scale manufacturing, enabling early detection of issues and improved control over cell behavior. Their novel mRNA method facilitates the development of consistent, functional stem cell lines, addressing the challenges of inconsistency and heterogeneity. Alt Atlas offers customized bioinformatic and AI services to control cell culture, along with novel human iPSCs and bovine iPSCs.
Target Audience
The primary target audience includes companies in the cultivated meat and cell therapy sectors, specifically those involved in large-scale cell manufacturing and seeking to optimize cell culture conditions and reduce production costs.
Features
- AI-powered cell health assessment providing results 50x faster with early detection capabilities.
- Multi-omics and imaging analysis in the cloud for comprehensive cell data insights.
- Custom assay development and QA/QC tools for tailored quality control processes.
- Predictive AI to monitor, control, and predict cell behavior in-vitro.
- Services for 100x cell media cost reduction.
- Customized cell tissue optimization services.
- Novel bovine iPSCs, non-GMO (coming soon).
- Novel human iPSCs, non-GMO (coming soon).